Portfolio company
Prometheus Life Technologies
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company produces human tissue organoids in microgravity for pharmaceutical researchers to improve drug development, testing and regenerative medicine.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
In-space manufacturing
This company produces pharmaceuticals and materials in microgravity using autonomous orbital laboratories for biotechnology and aerospace organisations.
Micro-gRx
This company develops lab-on-a-chip technology for biopharmaceutical customers to conduct microgravity research and cell-based drug screening experiments on the International Space Station.
BioOrbit
This company develops automated hardware for pharmaceutical companies to crystallise protein drug crystals in microgravity for large-scale biologic medicine manufacturing.
Orgonex
Orgonex develops automated bioreactor systems for organoid cultivation to assist researchers and pharmaceutical companies with large-scale cell expansion and drug development.
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
Outlier Space
This company develops reusable satellite platforms and capsules for microgravity manufacturing and research to serve biotechnology, pharmaceutical, and advanced materials industries.
Hesperos
This company develops multi-organ microchips for pharmaceutical researchers to test drug efficacy and safety without using animals.
